As Healio previously reported, Novo Nordisk ended the FLOW trial in October 2023 after results from an interim analysis met certain pre-specified criteria
The DoW Missed You: During this period of uncertainty, the Department of War maintained its strategic commitment to the program, viewing it as a vital mechanism for bridging mission gaps
Related Reading Tirzepatide Vs Zepbound Zepbound Tirzepatide Tirzepatide Vs Semaglutide Side Effects Zepbound Vs Tirzepatide Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
References: Save on Your Weight Loss Medications with BuzzRx
Why the chewable format matters
What if you screw it up